In spite of previous reports that showed a positive correlation between PD-L1 expression levels with a limited disease (LD) stage and a favourable outcome, currently, the role of PD-L1 expression in SCLC patients is controversial [8]. Here, CD274 is linked to small cell lung carcinoma.